Medicare Enrolled
Dr. Frank Greskovich, M.D.
Optician · Pensacola, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Greskovich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Greskovich? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Greskovich
Dr. Frank Greskovich is an optician in Pensacola, FL, with 20 years in practice. Based on federal Medicare data, Dr. Greskovich performed 51,919 Medicare services across 4,975 unique beneficiaries.
Between the years covered by Open Payments, Dr. Greskovich received a total of $7,493 from 54 pharmaceutical and/or device companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Greskovich is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in FL$ $7,493 industry payments
Medicare Practice Summary
Medicare Utilization ↗51,919
Medicare services
Top 2% in FL for optician
4,975
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,596 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection | 32,610 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 6,550 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 2,760 | $19 | $46 |
| Identification of organisms by genetic analysis, amplified probe technique | 2,052 | $34 | $156 |
| Office visit, established patient (30-39 min) | 1,279 | $88 | $224 |
| Automated urinalysis | 1,100 | $2 | $16 |
| Injection, gadobenate dimeglumine (multihance), per ml | 630 | $1 | $16 |
| Office visit, established patient (20-29 min) | 525 | $58 | $148 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 513 | $69 | $364 |
| Injection, triptorelin pamoate, 3.75 mg | 465 | $288 | $2,196 |
| Yeast/candida DNA test | 342 | $34 | $123 |
| Infectious disease DNA/RNA test | 342 | $34 | $161 |
| Bladder ultrasound after voiding | 236 | $7 | $94 |
| Diagnostic exam of bladder and urethra using an endoscope | 214 | $179 | $664 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 171 | $34 | $177 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 171 | $34 | $149 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 171 | $34 | $149 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 171 | $34 | $123 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 171 | $34 | $123 |
| Drug injection, under skin or into muscle | 166 | $10 | $93 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 135 | $474 | $1,380 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 125 | $25 | $141 |
| X-ray of abdomen, 1 view | 121 | $22 | $84 |
| New patient office visit (45-59 min) | 84 | $117 | $343 |
| Blood creatinine level | 68 | $5 | $30 |
| Initial hospital admission, moderate complexity | 66 | $105 | $297 |
| Mri scan of pelvis before and after contrast | 57 | $274 | $3,458 |
| Ceftriaxone antibiotic injection | 56 | $0 | $36 |
| Complete ultrasound scan behind abdominal cavity | 53 | $64 | $361 |
| Biopsy of prostate gland | 46 | $106 | $730 |
| Ultrasound scan of pelvic region through rectum | 46 | $26 | $418 |
| Hospital follow-up visit, low complexity | 45 | $40 | $115 |
| Ct scan of abdomen and pelvis before and after contrast | 42 | $271 | $1,776 |
| Simple change of bladder tube | 37 | $64 | $367 |
| Office visit, established patient, complex (40-54 min) | 34 | $135 | $301 |
| Simple insertion of temporary bladder tube | 33 | $47 | $249 |
| Ct scan of abdomen and pelvis without contrast | 25 | $143 | $892 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 23 | $592 | $2,644 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 22 | $286 | $898 |
| Ct scan of abdomen before and after contrast | 21 | $183 | $1,192 |
| Insertion of stent in ureter using an endoscope | 20 | $99 | $1,986 |
| Shock wave crushing of kidney stones | 19 | $463 | $3,538 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 19 | $1,199 | $4,120 |
| Instillation of anti-cancer drug into bladder | 16 | $66 | $420 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $315 | $1,272 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 14 | $216 | $1,621 |
| Chest X-ray, 2 views | 14 | $25 | $96 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 12 | $26 | $606 |
| Insertion of device into abdomen with pressure and urine flow rate study | 12 | $150 | $884 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
84.6% medium
15.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,493
Total received (2018-2024)
Avg $1,070/year across 7 years
Top 18% in FL for optician
54
Companies
381
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,785 (90.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$708 (9.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$997
2023$996
2022$1,443
2021$1,092
2020$412
2019$1,182
2018$1,371
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$1,600
Coloplast Corp
$640
Janssen Biotech, Inc.
$573
ABBVIE INC.
$520
PFIZER INC.
$463
Sumitomo Pharma America, Inc.
$447
Myovant Sciences Inc.
$259
COLOPLAST CORP
$220
Allergan Inc.
$217
180 Medical, Inc.
$184
Allergan, Inc.
$177
UROVANT SCIENCES INC
$170
Endo Pharmaceuticals Inc.
$161
Medtronic USA, Inc.
$124
Janssen Scientific Affairs, LLC
$118
Medtronic, Inc.
$111
Blue Earth Diagnostics Limited
$97
Intuitive Surgical, Inc.
$91
Ferring Pharmaceuticals Inc.
$88
Rochester Medical Corporation
$81
UroGen Pharma, Inc.
$80
Dornier MedTech America, Inc
$74
AbbVie, Inc.
$68
PROCEPT BioRobotics Corporation
$67
Boston Scientific Corporation
$61
Bayer Healthcare Pharmaceuticals Inc.
$60
BLUEWIND MEDICAL
$60
Merck Sharp & Dohme LLC
$59
TOLMAR Pharmaceuticals, Inc.
$53
Verity Pharmaceuticals Inc.
$42
Endo USA, Inc.
$40
Amgen Inc.
$37
Edwards Lifesciences Corporation
$32
Myriad Genetic Laboratories, Inc.
$32
AstraZeneca Pharmaceuticals LP
$32
AbbVie Inc.
$29
Sun Pharmaceutical Industries Inc.
$27
Bayer HealthCare Pharmaceuticals Inc.
$27
UROGEN PHARMA, INC.
$25
Novartis Pharmaceuticals Corporation
$24
ROCHESTER MEDICAL CORPORATION
$23
PROGENICS PHARMACEUTICALS, INC.
$23
Tempus AI, Inc
$21
Progenics Pharmaceuticals, Inc.
$19
CIVCO Medical Instruments
$19
Clarus Therapeutics Inc.
$17
Tolmar, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$15
Mission Pharmacal Company
$14
BIOPROTECT MEDICAL, INC.
$13
Avadel Specialty Pharmaceuticals, LLC
$12
Teva Pharmaceuticals USA, Inc.
$12
Antares Pharma, Inc.
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 37.5% of total payments
Associated products mentioned in payments ›
ADVANTAGE FIT · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BENDEKA · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX - UROLOGY · BOTOX THERAPEUTIC · CURE TWIST · Consumables & Accessories · DARZALEX · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENTLECATH · IMBRUVICA · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lumenis Pulse 120H · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PYLARIFY · Prolaris · Prolia · PureWick Female External Catheter · REVI · REZUM · SPEEDICATH · SpeediCath · TITAN · TOVIAZ · Trelstar · Uribel · VESICARE · Veozah · XIAFLEX · XT CDX · XTANDI · XYOSTED · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $14 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
56
Per 100K population
17.3
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Greskovich is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 18%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Greskovich experienced with testosterone injection?
Based on Medicare claims data, Dr. Greskovich performed 32,610 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Greskovich receive payments from pharmaceutical companies?
Yes. Dr. Greskovich received a total of $7,493 from 54 companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Greskovich's costs compare to other opticians in Pensacola?
Dr. Greskovich's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Greskovich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Pensacola
Browse opticians in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology